Target intelligence / Profile preview

CTNNA2 antisense RNA 1 (CTNNA2-AS1)

Target
CTNNA2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript (NAT), Non-coding RNA
01

Overview

CTNNA2 antisense RNA 1 (CTNNA2-AS1) is a long non-coding RNA transcribed from the opposite strand of the CTNNA2 (Catenin alpha-2) gene locus. As a natural antisense transcript, its sequence is complementary to that of the sense CTNNA2 mRNA, and it may regulate expression of CTNNA2 or other genes through mechanisms such as transcriptional interference, RNA masking, or chromatin remodeling. While antisense RNAs, including lncRNAs, play crucial roles in gene regulation, there is no direct evidence that CTNNA2-AS1 is itself a clinically actionable molecular target or is involved in specific diseases. Its biological functions may be inferred from general properties of long non-coding antisense RNAs, including modulation of sense gene transcription and participation in regulatory networks controlling cell fate, but further research is needed to clarify its precise roles[2][6].

Other names
CTNNA2-AS1Catenin alpha-2 antisense RNA 1
02

Mechanism of action

Not applicable; there are no drugs targeting this RNA, but antisense RNAs generally regulate gene expression by base-pairing with complementary mRNA, interfering with translation or RNA stability

03

Biological functions

Regulation of gene expression (including that of the linked CTNNA2 gene)Possible roles in transcriptional interference, RNA stability, or chromatin modification, as is typical for antisense RNAs
04

Disease associations

There are no direct, well-established connections in the literature between CTNNA2-AS1 and specific diseases. However, its sense gene CTNNA2 is implicated in nervous system development and cancer.

Beyond the preview

Go deeper on CTNNA2 antisense RNA 1 (CTNNA2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTNNA2 antisense RNA 1 (CTNNA2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call